PIPr Therapeutics
PrivateLast Round
Series A
Extension
Mar 1, 2021
Total Funding Raised
$23M
Company Overview
PIPr Therapeutics operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Series A Extension round in March 2021.
PIPr Therapeutics is a biotechnology company that develops small molecule inhibitors targeting metalloproteases for the treatment of inflammatory and immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PIPr Therapeutics Comparables
Compare PIPr Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Piton Therapeutics | 80% | |
| Symberix, Inc. | 80% | |
| Giiant Pharma Inc. | 76% |
For institutional investors. Book with your work email.
PIPr Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 1, 2021 | ||||
| Series A | Jun 10, 2019 |
For institutional investors. Book with your work email.
PIPr Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A Extension |
| Hatteras Venture Partners | Series A, Series A Extension |
| Osage University Partners | Series A, Series A Extension |
| Elm Street Ventures | Series A, Series A Extension |
| Johnson & Johnson Innovation – JJDC | Series A |
| Malin PLC | Series A |
PIPr Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PIPr Therapeutics's valuation, stock price, and market status.
Is PIPr Therapeutics a public or private company?
PIPr Therapeutics is a private company.
What is the current stock price of PIPr Therapeutics?
PIPr Therapeutics is a private company, so its shares have no public market price. Caplight tracks PIPr Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PIPr Therapeutics worth (valuation)?
Valuation information for PIPr Therapeutics is not publicly available.
Can I buy PIPr Therapeutics stock?
PIPr Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PIPr Therapeutics's last funding round?
PIPr Therapeutics's most recent funding round was Series A Extension on March 1, 2021.
Who are the main investors in PIPr Therapeutics?
Key investors in PIPr Therapeutics include Hatteras Venture Partners.
Will PIPr Therapeutics IPO soon?
No public IPO plans have been announced for PIPr Therapeutics.
How can I track PIPr Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in PIPr Therapeutics's shares on secondary markets.